Recent advances in specific immunotherapy for allergic rhinitis

J. Bousquet,Adan Hejjaoui,F. Michel
DOI: https://doi.org/10.1111/j.1365-2222.1991.tb01738.x
1991-05-01
Abstract:Specific immunotherapy (IT) is a very common treatment in many parts of the world and is effective under optimal conditions including a demonstrated IgE mediated disease, a high quality extract, an optimal allergen dose and a correct indication. However, it is still controversial since many protocols have been devised empirically, some allergens are still poorly defined, the mechanisms of action are not yet clear, and allergen injections expose to life-threatening reactions. The most common form of administration is the subcutaneous route but oral, sublingual or nasal IT might also be effective.
What problem does this paper attempt to address?